← Back to Search

Supervised Exercise for Bone Cancer

N/A
Waitlist Available
Led By Valerae O Lewis
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients must have a new diagnosis of primary bone tumor, and whose treatment plan includes surgery
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at least 4 weeks
Awards & highlights

Study Summary

This trial looks at whether exercising before surgery can improve fitness in patients with bone cancer.

Who is the study for?
This trial is for patients newly diagnosed with primary bone tumors who are planning to have surgery and will receive at least 4 weeks of chemotherapy before the operation. They must be willing to wear a Fitbit and get their main cancer treatment at MD Anderson Cancer Center. Those with neurological or structural issues that prevent safe exercise, severe co-morbid illnesses, or cognitive disorders affecting safety adherence cannot join.Check my eligibility
What is being tested?
The study is testing whether supervised exercise can improve physical fitness in bone cancer patients before they undergo surgery. Participants will engage in an exercise regimen while wearing an activity monitor (Fitbit) to track their progress.See study design
What are the potential side effects?
While not explicitly mentioned, potential side effects may include typical risks associated with physical activity such as muscle strain, fatigue, joint pain, and increased risk of injury especially since participants have bone tumors.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been newly diagnosed with a bone tumor and will undergo surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at least 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and at least 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility defined as at least 10 of out 15 patients in the supervised exercise group complete more than or equal to 75% (9 of 12 sessions) supervised physical therapy exercise sessions
Secondary outcome measures
Body Weight Changes
Blood coagulation tests

Trial Design

2Treatment groups
Experimental Treatment
Group I: Group II (fitbit)Experimental Treatment1 Intervention
Patients wear a fitbit.
Group II: Group I (supervised exercise)Experimental Treatment1 Intervention
Patients wear a fitbit and undergo supervised physical therapy exercise sessions over 40 minutes 3-5 times a week for at least 4 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Activity Monitor
2013
N/A
~320
Exercise Intervention
2016
Completed Phase 4
~1330

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
2,986 Previous Clinical Trials
1,789,469 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,717 Previous Clinical Trials
40,953,319 Total Patients Enrolled
Valerae O LewisPrincipal InvestigatorM.D. Anderson Cancer Center
3 Previous Clinical Trials
410 Total Patients Enrolled

Media Library

Supervised Exercise Clinical Trial Eligibility Overview. Trial Name: NCT02893397 — N/A
Bone Cancer Research Study Groups: Group I (supervised exercise), Group II (fitbit)
Bone Cancer Clinical Trial 2023: Supervised Exercise Highlights & Side Effects. Trial Name: NCT02893397 — N/A
Supervised Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT02893397 — N/A
~1 spots leftby Aug 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top